| Literature DB >> 34472665 |
Yan Zheng1,2,3, Tianshui Lei2, Guangfu Jin4, Haiyang Guo5, Nasha Zhang6, Jie Chai7, Mengyu Xie2, Yeyang Xu2, Tianpei Wang4, Jiandong Liu2, Yue Shen2, Yemei Song2, Bowen Wang2, Jinming Yu6, Ming Yang2.
Abstract
Genome-wide association studies (GWAS) have identified multiple gastric cancer risk loci and several protein-coding susceptibility genes. However, the role of long-noncoding RNAs (lncRNAs) transcribed from these risk loci in gastric cancer development and progression remains to be explored. Here, we functionally characterize a lncRNA, lncPSCA, as a novel tumor suppressor whose expression is fine-regulated by a gastric cancer risk-associated genetic variant. The rs2978980 T > G change in an intronic enhancer of lncPSCA interrupts binding of transcription factor RORA, which down-regulates lncPSCA expression in an allele-specific manner. LncPSCA interacts with DDX5 and promotes DDX5 degradation through ubiquitination. Increased expression of lncPSCA results in low levels of DDX5, less RNA polymerase II (Pol II) binding with DDX5 in the nucleus, thus activating transcription of multiple p53 signaling genes by Pol II. These findings highlight the importance of functionally annotating lncRNAs in GWAS risk loci and the great potential of modulating lncRNAs as innovative cancer therapy.Entities:
Keywords: DDX5; Pol II; gastric cancer; lncPSCA; risk variant
Mesh:
Substances:
Year: 2021 PMID: 34472665 PMCID: PMC8567296 DOI: 10.15252/embr.202152707
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807